Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-one analysts that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation, fifteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $24.8382.
A number of brokerages recently issued reports on CORZ. Canaccord Genuity Group increased their target price on shares of Core Scientific from $17.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, March 4th. HC Wainwright reaffirmed a “buy” rating and set a $25.00 price objective on shares of Core Scientific in a research note on Tuesday, March 3rd. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price objective for the company in a report on Thursday, December 18th. LADENBURG THALM/SH SH cut their target price on shares of Core Scientific from $24.50 to $23.75 and set a “buy” rating for the company in a research note on Tuesday, March 3rd. Finally, Cantor Fitzgerald reduced their target price on Core Scientific from $26.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd.
View Our Latest Analysis on Core Scientific
Hedge Funds Weigh In On Core Scientific
Core Scientific Price Performance
Shares of NASDAQ:CORZ opened at $14.86 on Monday. The business’s fifty day moving average price is $17.27 and its two-hundred day moving average price is $16.99. Core Scientific has a fifty-two week low of $6.20 and a fifty-two week high of $23.63. The stock has a market capitalization of $4.69 billion, a price-to-earnings ratio of 12.70 and a beta of 6.87.
Core Scientific (NASDAQ:CORZ – Get Free Report) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.69. The company had revenue of $79.76 million for the quarter, compared to the consensus estimate of $118.45 million. During the same period in the previous year, the business posted ($0.69) earnings per share. The firm’s revenue was down 16.0% compared to the same quarter last year. Research analysts expect that Core Scientific will post 0.52 EPS for the current fiscal year.
Key Headlines Impacting Core Scientific
Here are the key news stories impacting Core Scientific this week:
- Positive Sentiment: Core Scientific secured a $1.0 billion loan from Morgan Stanley to fund its AI pivot and provide liquidity for growth initiatives — this materially reduces near‑term financing risk and supports capital spending for compute/AI activities, which is constructive for valuation if execution follows. Core Scientific secures $1 billion loan
- Positive Sentiment: HC Wainwright reiterated a “Buy” rating, lifted FY‑2026 estimates (now $0.33 EPS from $0.16 previously) and published quarterly EPS forecasts with a $25 price target — analyst upgrade increases upside narrative and can buoy investor sentiment. HC Wainwright Reiterates Buy
- Positive Sentiment: Needham & Company upgraded Core Scientific — another independent analyst endorsement that may attract buyers or support a rerating if momentum continues. Needham upgrades CORZ
- Neutral Sentiment: Short‑interest reports show 0 shares and produce NaN changes and a 0.0 days‑to‑cover figure — this appears to be a data anomaly and is not reliable as a signal of bearish positioning. (No actionable short‑squeeze implications absent corrected data.)
- Negative Sentiment: Ladenburg Thalmann/SH lowered expectations for CORZ, which could weigh on sentiment and increase selling pressure among investors focused on near‑term fundamentals. Ladenburg lowers expectations
- Negative Sentiment: Recent results were mixed: Core beat Q4 EPS but missed revenue estimates and saw year‑over‑year revenue decline — ongoing top‑line pressure means the market remains sensitive to execution risk on the AI pivot and margin recovery, which can cap near‑term upside.
About Core Scientific
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
See Also
- Five stocks we like better than Core Scientific
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
